| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |